Report Detail

Pharma & Healthcare Global (United States, European Union and China) Intravenous (IV) Solution Market Research Report 2019-2025

  • RnM3686048
  • |
  • 20 August, 2019
  • |
  • Global
  • |
  • 119 Pages
  • |
  • QYResearch
  • |
  • Pharma & Healthcare

Intravenous (IV) Solution are intended to be administered to the patients which are deficient in nutrients or at the time of serious dehydration. These solutions are given to the patients whose fluid volume or body nutrients falls.
Many companies manufactures packaged intravenous fluids or products or compounds which can be mixed with sterile water to prepare a solution for intravenous administration. The market for intravenous solutions is growing swiftly.
In 2019, the market size of Intravenous (IV) Solution is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Intravenous (IV) Solution.

This report studies the global market size of Intravenous (IV) Solution, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Intravenous (IV) Solution sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
ICU Medical
B. Braun Melsungen
Fresenius Kabi
Baxter
Amanta Healthcare
Terumo Medical Corporation
Grifols
...

Market Segment by Product Type
Total Parenteral Solution
Peripheral Parenteral Solution

Market Segment by Application
Hospitals & Clinics
Ambulatory
Homecare

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Intravenous (IV) Solution status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Intravenous (IV) Solution manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Intravenous (IV) Solution are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Intravenous (IV) Solution Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Total Parenteral Solution
      • 1.3.3 Peripheral Parenteral Solution
    • 1.4 Market Segment by Application
      • 1.4.1 Global Intravenous (IV) Solution Market Share by Application (2019-2025)
      • 1.4.2 Hospitals & Clinics
      • 1.4.3 Ambulatory
      • 1.4.4 Homecare
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Intravenous (IV) Solution Market Size
      • 2.1.1 Global Intravenous (IV) Solution Revenue 2014-2025
      • 2.1.2 Global Intravenous (IV) Solution Sales 2014-2025
    • 2.2 Intravenous (IV) Solution Growth Rate by Regions
      • 2.2.1 Global Intravenous (IV) Solution Sales by Regions 2014-2019
      • 2.2.2 Global Intravenous (IV) Solution Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Intravenous (IV) Solution Sales by Manufacturers
      • 3.1.1 Intravenous (IV) Solution Sales by Manufacturers 2014-2019
      • 3.1.2 Intravenous (IV) Solution Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Intravenous (IV) Solution Revenue by Manufacturers (2014-2019)
      • 3.2.2 Intravenous (IV) Solution Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Intravenous (IV) Solution Market Concentration Ratio (CR5 and HHI)
    • 3.3 Intravenous (IV) Solution Price by Manufacturers
    • 3.4 Key Manufacturers Intravenous (IV) Solution Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Intravenous (IV) Solution Market
    • 3.6 Key Manufacturers Intravenous (IV) Solution Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Total Parenteral Solution Sales and Revenue (2014-2019)
      • 4.1.2 Peripheral Parenteral Solution Sales and Revenue (2014-2019)
    • 4.2 Global Intravenous (IV) Solution Sales Market Share by Type
    • 4.3 Global Intravenous (IV) Solution Revenue Market Share by Type
    • 4.4 Intravenous (IV) Solution Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Intravenous (IV) Solution Sales by Application

    6 United States

    • 6.1 United States Intravenous (IV) Solution Breakdown Data by Company
    • 6.2 United States Intravenous (IV) Solution Breakdown Data by Type
    • 6.3 United States Intravenous (IV) Solution Breakdown Data by Application

    7 European Union

    • 7.1 European Union Intravenous (IV) Solution Breakdown Data by Company
    • 7.2 European Union Intravenous (IV) Solution Breakdown Data by Type
    • 7.3 European Union Intravenous (IV) Solution Breakdown Data by Application

    8 China

    • 8.1 China Intravenous (IV) Solution Breakdown Data by Company
    • 8.2 China Intravenous (IV) Solution Breakdown Data by Type
    • 8.3 China Intravenous (IV) Solution Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Intravenous (IV) Solution Breakdown Data by Company
    • 9.2 Rest of World Intravenous (IV) Solution Breakdown Data by Type
    • 9.3 Rest of World Intravenous (IV) Solution Breakdown Data by Application
    • 9.4 Rest of World Intravenous (IV) Solution Breakdown Data by Countries
      • 9.4.1 Rest of World Intravenous (IV) Solution Sales by Countries
      • 9.4.2 Rest of World Intravenous (IV) Solution Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 ICU Medical
      • 10.1.1 ICU Medical Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Intravenous (IV) Solution
      • 10.1.4 Intravenous (IV) Solution Product Introduction
      • 10.1.5 ICU Medical Recent Development
    • 10.2 B. Braun Melsungen
      • 10.2.1 B. Braun Melsungen Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Intravenous (IV) Solution
      • 10.2.4 Intravenous (IV) Solution Product Introduction
      • 10.2.5 B. Braun Melsungen Recent Development
    • 10.3 Fresenius Kabi
      • 10.3.1 Fresenius Kabi Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Intravenous (IV) Solution
      • 10.3.4 Intravenous (IV) Solution Product Introduction
      • 10.3.5 Fresenius Kabi Recent Development
    • 10.4 Baxter
      • 10.4.1 Baxter Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Intravenous (IV) Solution
      • 10.4.4 Intravenous (IV) Solution Product Introduction
      • 10.4.5 Baxter Recent Development
    • 10.5 Amanta Healthcare
      • 10.5.1 Amanta Healthcare Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Intravenous (IV) Solution
      • 10.5.4 Intravenous (IV) Solution Product Introduction
      • 10.5.5 Amanta Healthcare Recent Development
    • 10.6 Terumo Medical Corporation
      • 10.6.1 Terumo Medical Corporation Company Details
      • 10.6.2 Company Description and Business Overview
      • 10.6.3 Sales, Revenue and Market Share of Intravenous (IV) Solution
      • 10.6.4 Intravenous (IV) Solution Product Introduction
      • 10.6.5 Terumo Medical Corporation Recent Development
    • 10.7 Grifols
      • 10.7.1 Grifols Company Details
      • 10.7.2 Company Description and Business Overview
      • 10.7.3 Sales, Revenue and Market Share of Intravenous (IV) Solution
      • 10.7.4 Intravenous (IV) Solution Product Introduction
      • 10.7.5 Grifols Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Intravenous (IV) Solution Sales Channels
      • 11.2.2 Intravenous (IV) Solution Distributors
    • 11.3 Intravenous (IV) Solution Customers

    12 Market Forecast

    • 12.1 Global Intravenous (IV) Solution Sales and Revenue Forecast 2019-2025
    • 12.2 Global Intravenous (IV) Solution Sales Forecast by Type
    • 12.3 Global Intravenous (IV) Solution Sales Forecast by Application
    • 12.4 Intravenous (IV) Solution Forecast by Regions
      • 12.4.1 Global Intravenous (IV) Solution Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Intravenous (IV) Solution Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Intravenous (IV) Solution. Industry analysis & Market Report on Intravenous (IV) Solution is a syndicated market report, published as Global (United States, European Union and China) Intravenous (IV) Solution Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Intravenous (IV) Solution market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,614.16
      3,921.24
      5,228.32
      3,050.40
      4,575.60
      6,100.80
      501,446.40
      752,169.60
      1,002,892.80
      273,650.40
      410,475.60
      547,300.80
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report